BRIEF published on 06/03/2026 at 22:05, 5 months 9 days ago FP Newspapers Inc. obtient l'approbation lors de l'assemblée générale annuelle des actionnaires Actionnaires Gouvernance D'Entreprise Réunion Annuelle FP Newspapers Inc. Élection Du Directeur
BRIEF published on 06/03/2026 at 20:34, 5 months 9 days ago OSE Immunotherapeutics to Hold Annual General Meeting on June 24, 2026 Annual General Meeting Shareholder Information OSE Immunotherapeutics Webcast Access Paris Event
BRIEF published on 06/03/2026 at 20:34, 5 months 9 days ago OSE Immunotherapeutics tiendra son assemblée générale annuelle le 24 juin 2026. Assemblée Générale Annuelle Informations Destinées Aux Actionnaires Accès À La Webdiffusion Immunothérapies OSE Événement De Paris
BRIEF published on 06/03/2026 at 20:34, 5 months 9 days ago Assemblée Générale d'OSE Immunotherapeutics : accès aux documents préparatoires Actionnaires Paris Assemblée Générale Documents Préparatoires OSE Immunotherapeutics
BRIEF published on 06/03/2026 at 20:34, 5 months 9 days ago OSE Immunotherapeutics General Assembly: access to preparatory documents Shareholders Paris General Assembly Preparatory Documents OSE Immunotherapeutics
BRIEF published on 06/03/2026 at 20:24, 5 months 9 days ago OSE Immunotherapeutics Reports 2025 Financial Results and Universal Registration Document Filing Universal Registration Document OSE Immunotherapeutics Cash Runway 2025 Financial Results IRIS Financing
BRIEF published on 06/03/2026 at 20:24, 5 months 9 days ago OSE Immunotherapeutics : Publication des résultats financiers 2025 Document D'Enregistrement Universel OSE Immunotherapeutics Stratégie De Financement Résultats Financiers 2025 Financement IRIS
BRIEF published on 06/03/2026 at 20:24, 5 months 9 days ago OSE Immunotherapeutics publie ses résultats financiers pour 2025 et dépose son document d'enregistrement universel. Document D'Enregistrement Universel Cash Runway Résultats Financiers 2025 Immunothérapies OSE Financement IRIS
BRIEF published on 06/03/2026 at 20:24, 5 months 9 days ago OSE Immunotherapeutics: Publication of 2025 Financial Results Universal Registration Document OSE Immunotherapeutics Funding Strategy 2025 Financial Results IRIS Funding
BRIEF published on 06/03/2026 at 20:10, 5 months 9 days ago Sparton Resources Moves to Semi-Annual Financial Reporting Financial Reporting Sparton Resources Semi-annual Reporting Venture Issuer CBO 51-933
Published on 11/13/2026 at 02:40, 5 hours 12 minutes ago Jaguar Mining Reports Third Quarter 2026 Results with 67% Growth in Adjusted Net Income and 46% Higher Adjusted EBITDA
Published on 11/13/2026 at 02:10, 5 hours 42 minutes ago Amarc to Participate in Consolidation of Aurora West Through Aurora Minerals LTD
Published on 11/12/2026 at 23:25, 8 hours 27 minutes ago Renegade Gold Announces Bought Deal Private Placement for Gross Proceeds of C$5 Million
Published on 11/12/2026 at 23:05, 8 hours 47 minutes ago Caldwell Reports Fourth Quarter and Full Year Fiscal 2026 Results; Increases Quarterly Dividend and Declares a Special Dividend
Published on 11/12/2026 at 23:00, 8 hours 52 minutes ago Redwood AI Announces Chemical Risk Analysis Update to its AI-Powered Reactosphere Platform to Support Faster Reaction Safety Screening
Published on 11/13/2026 at 07:48, 3 minutes ago Nagarro releases unaudited Q3 2026 results, posts 2.7% constant currency growth for 9 months ended September 2026
Published on 11/13/2026 at 07:30, 22 minutes ago Mutares seeks early refinancing of the outstanding Bond 2023/2027 by increasing the Bond 2024/2029 by up to EUR 165 million
Published on 11/13/2026 at 07:29, 23 minutes ago Bechtle delivers double-digit growth in business volume and EBT, raises 2026 forecast again
Published on 11/13/2026 at 07:15, 37 minutes ago EQS-Adhoc: ams-OSRAM AG: ams OSRAM delivers continued core growth despite mixed end-market demand, led by strong Opto Semiconductors
Published on 11/13/2026 at 07:14, 38 minutes ago Fabasoft Reports Revenue and Earnings Growth in the First Half of Fiscal Year 2026/2027
Published on 11/12/2026 at 23:12, 8 hours 39 minutes ago Belgrano continues the implementation of its public share buyback offer (OPRA)
Published on 11/12/2026 at 23:12, 8 hours 39 minutes ago Belgrano poursuit la mise en oeuvre de son projet d'OPRA
Published on 11/12/2026 at 23:00, 8 hours 52 minutes ago Assemblée générale du 12 novembre 2026 : quorum non atteint - Convocation d’une seconde assemblée générale le 27 novembre 2026
Published on 11/12/2026 at 18:36, 13 hours 15 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/10/2026
Published on 11/12/2026 at 18:36, 13 hours 15 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/10/2026
